Former Top Gun Pilot on Hallucinogens, PTSD & the Abyss | Brian "Ponch" Rivera at Macrocosm 2026

Why It Matters

Effective debriefing and open‑mind treatment options can save lives and boost performance, urging businesses and policymakers to rethink risk management and drug regulations.

Key Takeaways

• Apply PBED cycle—plan, brief, execute, debrief—to improve team performance.
• Debriefing forces reality check, updating world models for better decisions.
• Even perfect risk management can’t prevent catastrophic outcomes in complex systems.
• Veterans face high suicide rates; psychedelic therapy shows promising recovery.
• Ibogain, a Schedule‑I plant medicine, challenges current drug policy assumptions.

Summary

The talk by former Top‑Gun pilot Brian “Ponch” Rivera blends military decision‑making, team dynamics, and the mental‑health crisis among veterans. He frames his experience in the Bay of Bengal as a case study of how world models—our internal maps of reality—must be constantly shaken through the PBED (plan‑brief‑execute‑debrief) cycle to stay accurate.

Rivera stresses that the debrief is the only phase that forces a reality check, updating the world model and exposing hidden risks. He recounts a night‑time combat check‑ride where a missing aircraft and a risky maneuver led to a fatal loss, illustrating that even flawless risk hedges can’t prevent catastrophe in complex adaptive systems. He then pivots to data: over 7,000 combat deaths since 9/11, 140,000 veteran suicides, and daily suicide estimates ranging from 17 to 44.

Personal stories punctuate the narrative. The loss of his roommate, the moral injury of Mark Slider’s botched laser‑guided bomb, and the subsequent descent into substance abuse highlight the human cost of systemic failures. Rivera describes a psychedelic‑assisted therapy retreat in Tijana, where veterans—including former NFL player Robert Gallery—used ibogaine, a Schedule‑I plant medicine, to confront trauma, challenging prevailing drug‑policy assumptions.

The implications are clear: organizations must institutionalize rigorous debriefs, treat mental health as a systemic issue rather than a symptom, and reconsider prohibitive drug schedules that block potentially life‑saving treatments. Applying military‑grade decision frameworks to corporate teams could improve performance, while embracing emerging therapies may reduce veteran suicide rates.

Original Description

#hallucinogens #ptsd #veteransupport

0:00 World Models, Check Rides, and Decisions Under Uncertainty

3:25 Night Vision, 7 Gs, and 700 Miles of Open Ocean Darkness

6:19 Swapping Seats, Losing Aircraft 104, and Survivor’s Guilt

8:00 The 20-to-1 Veteran Suicide Ratio and the SSRIs the System Prescribes

9:55 Mark “Slider” Keller, a Moral Injury, and Seven Years on a Couch

14:05 “Just Say No,” the War on Drugs, and the Lies It Installed

16:42 Tijuana, Ibogaine, and a Schedule I That’s Wrong

17:58 The Stanford Study, Trump’s April 2026 Executive Order, and What Ibogaine Actually Does

20:16 Controlled Hallucination and Why Your Brain Lies to You

22:58 Attractor States, Sleds, and Shaking the Snow Globe

25:49 The Trauma Isn’t the Event, It’s the Response

28:12 Meeting Veterans at the Curb and 500 Lives Touched

30:43 Don’t Let Anyone You Love Fly Into the Abyss

Brian "Ponch" Rivera's 28-year U.S. Navy career as a F-14 Top Gun aviator is one marked by exceptional leadership and operational expertise. But it wasn't without tremendous sacrifice.

He opens in the cockpit on a 2001 training mission over the Bay of Bengal, with the roommate he swapped seats with, who never came back. Through his emotional retelling, Rivera explains how, in a complex adaptive system, you can make all the right decisions, have all the right hedges on, and still end up with a catastrophic outcome.

Since 9/11, just over 7,000 American service members have died in combat. In that same period, 140,000 veterans have died by suicide — the VA puts the rate at 17 a day; independent research puts it as high as 44 once overdoses are counted honestly. The system's answer is SSRIs, benzos, sleep aids, and painkillers. They're treating symptoms, not the system.

Rivera traces the path from the "Just Say No" era of the 1970s War on Drugs to his story of ibogaine treatment in Tijuana alongside his friend Mark "Slider" Keller, who'd spent seven years on a couch after a moral injury in combat and was injecting cocaine by the time they boarded the plane.

A Stanford study of 30 special operators showed PTSD symptoms down 88%, depression down 87%, and anxiety down 81% one month after a single ibogaine treatment.

The medicine — still DEA Schedule I, "no accepted medical use" — interrupts opioid, meth, cocaine, and alcohol addiction within 24 to 36 hours and rebuilds severed neural connections. Rivera's work with Veterans Exploring Treatment Solutions helped push it from the underbelly of Tijuana to the White House in five years, culminating in President Trump's April 2026 executive order opening federal funding for ibogaine research.

Weaving together predictive processing, controlled hallucination, fractal attractor dynamics, and Neil Howe's Fourth Turning, Rivera makes the case that the trauma isn't the event — it's the response.